Anticoagulation during percutaneous coronary intervention in diabetics--is simpler always better?
Meier
Pascal
P
Division of Cardiovascular Medicine, University of Michigan Cardiovascular Center, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-5853, USA.
Gurm
Hitinder S
HS
D015906:Angioplasty, Balloon, Coronary; D000925:Anticoagulants / Q000627:therapeutic use*; D003324:Coronary Artery Disease / Q000209:etiology* / Q000628:therapy*; D048909:Diabetes Complications / Q000150:complications*; D006470:Hemorrhage / Q000453:epidemiology; D006493:Heparin / Q000627:therapeutic use; D006629:Hirudins; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control*; D010446:Peptide Fragments / Q000627:therapeutic use; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D011994:Recombinant Proteins / Q000627:therapeutic use; D012307:Risk Factors; D020521:Stroke / Q000517:prevention & control*
D000925:Anticoagulants; D006629:Hirudins; D010446:Peptide Fragments; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D011994:Recombinant Proteins; D006493:Heparin; C074619:bivalirudin